BE869509A - Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique - Google Patents

Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique

Info

Publication number
BE869509A
BE869509A BE789002A BE1009002A BE869509A BE 869509 A BE869509 A BE 869509A BE 789002 A BE789002 A BE 789002A BE 1009002 A BE1009002 A BE 1009002A BE 869509 A BE869509 A BE 869509A
Authority
BE
Belgium
Prior art keywords
preparation
therapeutic use
pyrazoles substituted
pyrazoles
substituted
Prior art date
Application number
BE789002A
Other languages
English (en)
Inventor
G D Diana
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of BE869509A publication Critical patent/BE869509A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE789002A 1977-08-05 1978-08-04 Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique BE869509A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/822,246 US4171365A (en) 1977-08-05 1977-08-05 Antiviral aryloxyalkylpyrazoles

Publications (1)

Publication Number Publication Date
BE869509A true BE869509A (fr) 1979-02-05

Family

ID=25235560

Family Applications (1)

Application Number Title Priority Date Filing Date
BE789002A BE869509A (fr) 1977-08-05 1978-08-04 Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique

Country Status (16)

Country Link
US (1) US4171365A (fr)
JP (1) JPS5430175A (fr)
AU (1) AU515984B2 (fr)
BE (1) BE869509A (fr)
CA (1) CA1112244A (fr)
CH (1) CH635080A5 (fr)
DE (1) DE2834322A1 (fr)
DK (1) DK345778A (fr)
FR (2) FR2409988A1 (fr)
GB (1) GB2003859B (fr)
IE (1) IE47139B1 (fr)
IT (1) IT1099591B (fr)
LU (1) LU80078A1 (fr)
NL (1) NL7808179A (fr)
NZ (1) NZ187960A (fr)
SE (1) SE7808418L (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372976A (en) * 1981-08-07 1983-02-08 Sterling Drug Inc. Novel aryl-aliphatic ketone and its use as an antiviral agent
ZA846525B (en) * 1983-08-29 1985-04-24 Sterling Drug Inc (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
GB8807275D0 (en) * 1988-03-26 1988-04-27 Synphar Lab Inc Chemical compounds
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
DE4012409A1 (de) * 1990-04-19 1991-10-24 Basf Ag Hydrochinondiether, ihre herstellung und ihre verwendung
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
JP2004123732A (ja) * 2002-09-10 2004-04-22 Takeda Chem Ind Ltd ５員複素環化合物
WO2004024705A1 (fr) * 2002-09-10 2004-03-25 Takeda Pharmaceutical Company Limited Composes heterocycliques a cinq elements
US9169214B2 (en) 2012-12-21 2015-10-27 The Board Of Trustees Of The Leland Stanford Junior University Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
WO2016025129A1 (fr) 2014-08-14 2016-02-18 Alhamadsheh Mamoun M Conjugaison d'agents pharmaceutiquement actifs avec des ligands de transthyrétine par des liants réglables pour augmenter la demi-vie de sérum
EA201991921A1 (ru) 2017-02-17 2020-02-06 Эйдос Терапьютикс, Инк. Способы получения ag-10, его промежуточных соединений и их солей
AU2019239291A1 (en) 2018-03-23 2020-10-08 Eidos Therapeutics, Inc. Methods of treating TTR amyloidosis using AG10
CA3104695A1 (fr) 2018-08-17 2020-02-20 Eidos Therapeutics, Inc. Formules d'ag10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190888A (en) * 1963-08-22 1965-06-22 American Home Prod Aryloxyalkylpyrazole
US3326933A (en) * 1964-03-02 1967-06-20 Upjohn Co 3-alkyl-5-phenoxy-methylpyrazoles
US3746768A (en) * 1970-10-02 1973-07-17 Scm Corp Substituted phenyl ethers and thioethers as insect repellents
US4031246A (en) * 1973-07-23 1977-06-21 Sterling Drug Inc. Aryloxyalkyl diketones

Also Published As

Publication number Publication date
JPS5430175A (en) 1979-03-06
FR2409988B1 (fr) 1982-07-16
US4171365A (en) 1979-10-16
FR2409989A1 (fr) 1979-06-22
SE7808418L (sv) 1979-02-06
LU80078A1 (fr) 1979-05-15
CH635080A5 (fr) 1983-03-15
DK345778A (da) 1979-02-06
AU3839778A (en) 1980-01-31
IT1099591B (it) 1985-09-18
NZ187960A (en) 1980-12-19
IT7826458A0 (it) 1978-08-03
IE781479L (en) 1979-02-05
IE47139B1 (en) 1983-12-28
GB2003859B (en) 1982-03-03
GB2003859A (en) 1979-03-21
CA1112244A (fr) 1981-11-10
AU515984B2 (en) 1981-05-14
FR2409989B1 (fr) 1981-10-16
DE2834322A1 (de) 1979-02-15
FR2409988A1 (fr) 1979-06-22
NL7808179A (nl) 1979-02-07

Similar Documents

Publication Publication Date Title
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
BE869509A (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
MX148110A (es) Mejoras en jeringa
BE884300A (fr) Amides, leur preparation et leur utilisation
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
LU80619A1 (fr) Derives heterosidiques de pleuromutiline et leur utilisation therapeutique
LU80673A1 (fr) Steroides,leur preparation et leur utilisation therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
FR2352804A1 (fr) 4-quinazolinyl-guanidines, leur preparation et leur application en therapeutique
BE825039A (fr) Leuco-colorants d'indolyl-methylene, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE880288A (fr) Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique
BE855591A (fr) Neoviridogriseines, leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: STERLING DRUG INC.

Effective date: 19840804